uliledlimab (TJD5) / Tracon Pharma, PT Kalbe Farma, I-Mab  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
uliledlimab (TJD5) / I-Mab, Tracon Pharma
NCT04869501: Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer

No Longer Available
N/A
US
TJ004309, Atezolizumab, Tecentriq
I-Mab Biopharma US Limited
Cancer
 
 

Download Options